Our data indicated that serum FGF21 levels at post-CABG are strongly associated with the incidence of MACE in patients with MI after CABG surgery, and measurement of circulating FGF21 levels may be beneficial for evaluating the risk of MACE in these MI patients. This evidence concerns the gene FGF21 and myocardial infarction.